This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Long-term Extension Study of PCI-32765 (Ibrutini...
Clinical trial

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Read time: 1 mins
Last updated:1st Sep 2013

The purpose of this study is to collect long-term safety and efficacy data for participants treated with PCI-32765 (Ibrutinib) and to provide ongoing access to PCI-32765 for participants who are currently enrolled in PCI-32765 studies that have been completed according to the parent protocol, are actively receiving treatment with PCI-32765, and who continue to benefit from PCI-32765 treatment.

Category Value
Study start date 2013-09-01

View full details